» Articles » PMID: 20427376

Robust and Expanded Norms for the Dementia Rating Scale

Overview
Specialties Neurology
Psychology
Date 2010 Apr 30
PMID 20427376
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The Dementia Rating Scale (DRS) is a widely used measure of global cognition, with age- and education-corrected norms derived from a cross-sectional sample of adults participating in Mayo's Older Americans Normative Studies (MOANS). In recent years, however, studies have indicated that cross-sectional normative samples of older adults represent an admixture of individuals who are indeed cognitively normal (i.e., disease-free) and individuals with incipient neurodegenerative disease. Theoretically, the "contamination" of cross-sectional normative samples with cases of preclinical dementia can lead to underestimation of the test mean and overestimation of the variance, thus reducing the clinical utility of the norms. Robust norming, in which dementia cases are removed from the normative cohort through longitudinal follow-up, is an alternative approach to norm development. The current study presents a reappraisal of the original MOANS DRS norms, provides robust and expanded norms based on a sample of 894 adults age 55 and over, and critically evaluates the benefits of robust norming.

Citing Articles

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia.

Weintraub D, Nair A, Kurth R, Brumm M, York M, Dobkin R medRxiv. 2024; .

PMID: 39711699 PMC: 11661337. DOI: 10.1101/2024.12.12.24318917.


Toward enhanced understanding and rigor: addressing limitations in studying dementia symptoms and caregiver interventions.

Nogueira G, Vidal W, Silva N Dement Neuropsychol. 2024; 18:e20240148.

PMID: 39697641 PMC: 11654083. DOI: 10.1590/1980-5764-DN-2024-0148.


Mayo normative studies: regression-based normative data for ages 30-91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency.

Karstens A, Christianson T, Lundt E, Machulda M, Mielke M, Fields J J Int Neuropsychol Soc. 2023; 30(4):389-401.

PMID: 38014536 PMC: 11014770. DOI: 10.1017/S1355617723000760.


ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.

You Y, Zhang Z, Sultana N, Ericsson M, Martens Y, Sun M Sci Adv. 2023; 9(37):eadi3647.

PMID: 37713494 PMC: 10881047. DOI: 10.1126/sciadv.adi3647.


Recent Advances in Neuropsychological Test Interpretation for Clinical Practice.

Kiselica A, Karr J, Mikula C, Ranum R, Benge J, Medina L Neuropsychol Rev. 2023; 34(2):637-667.

PMID: 37594687 DOI: 10.1007/s11065-023-09596-1.


References
1.
Lucas J, Ivnik R, Willis F, Ferman T, Smith G, Parfitt F . Mayo's Older African Americans Normative Studies: normative data for commonly used clinical neuropsychological measures. Clin Neuropsychol. 2005; 19(2):162-83. DOI: 10.1080/13854040590945265. View

2.
Lyness S, Hernandez I, Chui H, Teng E . Performance of Spanish speakers on the Mattis dementia rating scale (MDRS). Arch Clin Neuropsychol. 2006; 21(8):827-36. DOI: 10.1016/j.acn.2006.09.003. View

3.
Holtzer R, Goldin Y, Zimmerman M, Katz M, Buschke H, Lipton R . Robust norms for selected neuropsychological tests in older adults. Arch Clin Neuropsychol. 2008; 23(5):531-41. PMC: 2610426. DOI: 10.1016/j.acn.2008.05.004. View

4.
Sliwinski M, Lipton R, Buschke H, Stewart W . The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J Gerontol B Psychol Sci Soc Sci. 1996; 51(4):P217-25. DOI: 10.1093/geronb/51b.4.p217. View

5.
De Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K . Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology. 2008; 22(4):469-84. PMC: 2661242. DOI: 10.1037/0894-4105.22.4.469. View